Inhibition of Protein Phosphatase 2A Activity by Selective Electrophile Alkylation Damage
- 1 August 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 45 (33) , 10020-10029
- https://doi.org/10.1021/bi060551n
Abstract
Protein serine/threonine phosphatase 2A (PP2A) is a critical regulator of numerous cellular signaling processes and a potential target for reactive electrophiles that dysregulate phosphorylation-dependent signal transduction cascades. The predominant cellular form of PP2A is a heterotrimeric holoenzyme consisting of a structural A, a variable B, and a catalytic C subunit. We studied the modification of two purified PP2A holoenzyme complexes (ABαFLAGC and ABδFLAGC) with two different thiol-reactive electrophiles, biotinyl-iodoacetamidyl-3,6-dioxaoctanediamine (PEO-IAB) and the biotinamido-4-[4‘-(maleimidomethyl)cyclohexanecarboxamido]butane (BMCC). In vivo treatment of HEK 293 cells with these electrophiles resulted in alkylation of all three PP2A subunits. Electrophile treatment of the immunopurified FLAG-tagged holoenzymes produced a concentration-dependent adduction of PP2A subunits, as observed by Western blot analysis. Although both electrophiles labeled all three PP2A subunits, only BMCC inhibited the catalytic activity of both holoenzymes. Alkylation patterns in the A and B subunits were identical for the two electrophiles, but BMCC alkylated four Cys residues in the C subunit that were not labeled by PEO-IAB. Homology between the catalytic subunits of PP1 and PP2A enabled generation of a comparative model structure for the C subunit of PP2A. The model structure provided additional insight into contributions of specific BMCC−Cys adducts to PP2A enzyme inhibition. The results indicate that site selectivity of protein adduction should be a critical determinant of the ability of electrophiles to affect cellular signaling processes.Keywords
This publication has 18 references indexed in Scilit:
- Elucidating mechanisms of drug-induced toxicityNature Reviews Drug Discovery, 2005
- Phoslactomycin targets cysteine‐269 of the protein phosphatase 2A catalytic subunit in cellsFEBS Letters, 2005
- P-Mod: An Algorithm and Software To Map Modifications To Peptide Sequences Using Tandem MS DataJournal of Proteome Research, 2005
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- The predicted β12-β13 loop is important for inhibition of PP2Acα by the antitumor drug fostriecinFEBS Letters, 2001
- Cloning and characterization of Bδ, a novel regulatory subunit of protein phosphatase 2APublished by Wiley ,1999
- THE STRUCTURE AND MECHANISM OF PROTEIN PHOSPHATASES: Insights into Catalysis and RegulationAnnual Review of Biophysics, 1998
- Method to Correlate Tandem Mass Spectra of Modified Peptides to Amino Acid Sequences in the Protein DatabaseAnalytical Chemistry, 1995
- Purification of type 1 protein (serine/threonine) phosphatases by microcystin‐Sepharose affinity chromatographyFEBS Letters, 1994
- Mutagenesis of the catalytic subunit of rabbit muscle protein phosphatase-1Molecular and Cellular Biochemistry, 1993